☆ 4.3 Article

Clinical pharmacology of alogliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of Type 2 diabetes

Expert Review of Clinical Pharmacology (2009)

Journal

Expert Review of Clinical Pharmacology

Volume 2, Issue 6, Pages 589-600

Publisher

Informa UK Limited

DOI: 10.1586/ecp.09.45

Keywords

-

Categories

Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.